Sanofi-Aventis has expanded its My Child Matters programme, adding another seven new projects for improving cancer care for children in …
Sanofi-Aventis made large gains in emerging markets, vaccines and consumer healthcare last year, helping produce 8.5 billion euros in net …
Sanofi-Aventis has partnered with China’s Minsheng Pharmaceuticals to establish a new consumer healthcare joint venture. Sanofi will take a majority …
Sanofi-Aventis has appointed Han Regenauer vice president, consumer healthcare, Europe and global development. In his new role he will report …
Serge Weinberg has joined the board of directors at Sanofi-Aventis, replacing Gunter Thielen, who has resigned for personal reasons. The …
Sanofi-Aventis has doubled its capacity to manufacture syringe-delivered medicines with the opening of new production units at Le Trait, near …
Sanofi Pasteur has filed with US regulators a supplemental license application for its vaccine to protect against the H1N1 pandemic …
Sanofi-Aventis has promised its 2013 sales will at least match those the company made last year, despite facing huge and …
Sanofi-Aventis has rejected claims of a possible connection between its diabetes treatment Lantus and cancer. The possible link was reported …
Sanofi-Aventis is to set aside 100 million flu vaccine doses for the developing world in order to fight the emerging …
Plavix is to face competition from six generics in Europe, potentially decimating sales of Sanofi-Aventis' brand in the region. Plavix …
Sanofi-Aventis will pay 30 million euros (£26 million) for a manufacturing plant in Germany operated by Pfizer in a deal …